The community site for and by
developmental and stem cell biologists

Postdoctoral Position in Cardiovascular Development

Posted by , on 23 June 2017

Closing Date: 15 March 2021

A postdoctoral position is available in the laboratory of Dr. Sophie Astrof at Thomas Jefferson University to study roles of cell-extracellular matrix interactions during cardiovascular development and disease. My laboratory utilizes genetics, cell biology and confocal imaging to elucidate developmental and molecular mechanisms of aortic arch artery patterning and the formation of the cardiac outflow tract. These processes are essential for neonatal viability, and defects in the formation and remodeling of the outflow tract vasculature underlie common and severe forms of human congenital defects. Experience with genetic manipulation, embryology and cell biology is desirable. My laboratory is a part of a modern and well-equipped Center for Translational Medicine at Jefferson Medical College (http://www.jefferson.edu/university/research/researcher/researcher-faculty/astrof-laboratory.html) located in the heart of Philadelphia. To apply, send a letter of interest, CV and names and contact information of three references to sophie.astrof@gmail.com

Thumbs up (No Ratings Yet)
Loading...

Categories: Jobs

Navigate the archive

Use our Advanced Search tool to search and filter posts by date, category, tags and authors.

Postdoctoral position, Developmental Genetics, University of Colorado Anschutz Medical Campus

Posted by , on 22 June 2017

Closing Date: 15 March 2021

A postdoctoral position is immediately available at the University of Colorado Anschutz Medical Campus in Aurora, Colorado in David Clouthier’s lab to study molecular mechanisms regulating facial morphogenesis. The laboratory is currently investigating the molecular and cellular functions of basic helix-loop-helix transcription factors and non-coding RNAs in facial development, with an emphasis on understanding the regulatory landscape influenced by these factors and RNAs. This includes CRISPR/Cas9 model generation in mice and zebrafish. In addition, a systems biology approach is being taken to model early gene expression within the developing pharyngeal arches of mouse and zebrafish embryos in an attempt to create an in silico developmental program. Finally, new mutant mouse models being developed by KOMP2 are being screened in order to find novel genes regulating craniofacial and cardiovascular development. We use a combination of modern genetic approaches in both the mouse and zebrafish to address these topics.

Applicants should have a Ph.D. or M.D./Ph.D. and a strong background in developmental biology. Experience with mouse genetics and/or zebrafish embryology is a plus. Salary support will be based on the current NIH pay scale. In addition, individuals will be encouraged and supported to submit fellowship applications as part of an overall mentoring program. Please send a cover letter of your research interests and past research experience, CV and contact information for three references to Dr. David Clouthier (david.clouthier@ucdenver.edu).

Thumbs up (No Ratings Yet)
Loading...

Categories: Jobs

Postdoctoral position, Genetics and Development of Morphological Evolution, University of Oklahoma

Posted by , on 21 June 2017

Closing Date: 15 March 2021

A postdoctoral position is available in J.P. Masly’s lab at the University of Oklahoma (www.maslylab.com) to study the genetic, developmental, and evolutionary bases of morphological variation among Drosophila species. Our research focuses on understanding how evolutionary change at the genetic level directs variation in development that gives rise to species-specific phenotypic differences.

The successful candidate will have a Ph.D., and will also have a strong background and research interests in evolutionary biology, developmental biology, and genetics. Candidates with experience in Drosophila genetics and molecular biology are particularly encouraged to apply. The initial appointment will be made for one year, with a possible extension up to three years. Salary will be commensurate with experience and the start date is flexible.

To apply, visit https://jobs.ou.edu and submit the following materials for job position number 171344:

— A cover letter explaining why you would like to join the lab group and a statement of research interests
— Curriculum vitae, including a list of publications
— Contact details for two or three academic referees

Informal inquiries are welcome and should be sent to J.P. Masly (masly[at]ou.edu). For additional information visit http://www.maslylab.com/Opportunities.html.

The position is available immediately and will remain open until filled.

Thumbs up (No Ratings Yet)
Loading...

Categories: Jobs

Woods Hole images 2015, Round 2 – The winner

Posted by , on 21 June 2017

The votes are in for our latest Development cover competition with entries from the 2015 class of the Woods Hole Embryology Course. 

With 333 votes counted, we have a winner:

4th Place (13% of the votes) – Drosophila

3rd Place (25% of the votes) – Skate

2nd Place (26% of the votes) – Parhyale

1st Place (36% of the votes) – Crab

 

 

This cute crab was collected from a plankton tow Chiara Sinigaglia
 from the Observatoire Océanologique de Villefranche sur Mer/ CNRS, France. Congratulations Chiara! And thanks to our other entrants Amjad Askary, Longhua Guo, Maike Getwan, Nick Shikuma and Elena Boer.

Look out for another round in the coming weeks.

Thumbs up (1 votes)
Loading...

Tags:
Categories: Images

Photo Contest

Posted by , on 21 June 2017

Hello everyone!! My name is Nadia Edelsztein and I am a PhD student from Argentina working in the Reproductive and Development field!

I am addressing you all to ask for a big favour. I entered a photo contest a couple of weeks ago, held by the institute where I used to learn German. The idea was to show pictures that, somehow, made you see things differently or from a different perspective. I chose a photo of one of the control immunohistochemistry assays I have done during my PhD project. It is an epididymis section from a 9dpp mouse that got all curled up during mounting but still looks beautiful -to me, at least. I have entitled it “Neben” (,,Nebenhoden” is epididymis in German). Even though I do not compete for the big prizes, I am in the run for “people’s choice award” and it is the only picture related to Science. You can only vote once and through Facebook.

So…I would like to ask you all if you could vote for my photo and, if you wish to do so, share the link with friends, acquaintances, etc! I am posting my pic at the end of this message for you to see which one is it.

In order to vote, you will have to click the following link and a website will open (it is in Spanish, so I apologise for that). There, you have to click on my photo (if you want to do so…please want to do so!!) and the little circle next to it turns black. Then go to the bottom of the page and click on the green button that says “Enviar” (which means “send” in Spanish). After that, there will be something displayed on a new page (all in Spanish) saying something very similar to “Thank you for participating! The winners will be announced July 5th, etc”.

 

Link to vote: https://goetheinstitut.fbapp.io/b…/WAK8n5LzZRRA6LQzrwRNqbop…

 

Thank you all for taking the time to read this!! Thanks to The Node for allowing me to share this!! And I apologise for the long post!!

 

Here is Neben (isn’t it beautiful? ♥):

 

 

Cheers!!

Nadia

Thumbs up (1 votes)
Loading...

Categories: Images

NIH launches competition to develop human eye tissue in a dish

Posted by , on 21 June 2017

3-D Retina Organoid Challenge to spur breakthroughs in treating blinding diseases

The National Eye Institute (NEI), part of the National Institutes of Health, has opened the first stage of a federal prize competition designed to generate miniature, lab-grown human retinas. The retina is the light- sensitive tissue in the back of the eye. Over the next three years pending availability of funds, NEI plans to offer more than $1 million in prize money to spur development of human retina organoids.

“None of the model systems currently available to researchers match the complex architecture and functionality of the human retina,” said NEI Director Paul A. Sieving, M.D., Ph.D. “We are looking for new ideas to create standardized, reproducible 3-D retina organoids that can speed the discovery of treatments for diseases such as age-related macular degeneration and diabetic eye disease, both leading causes of blindness.”

Currently, more than 4.2 million people over age 40 in the U.S. are visually impaired or blind, and that number is expected to double by the year 2050.1 Major visual disorders among Americans have an estimated annual economic burden of more than $35.4 billion.2

Research models are more valuable the more closely they mimic human tissue. Researchers hope to use retina organoids to study how retinal cells interact under healthy and diseased conditions, and to test potential therapies.

 

Stage I: Ideas

The ideation stage of the 3-D Retina Organoid Challenge aims to generate innovative ideas that can later be turned into concrete concepts. Running until August 1, 2017, the total prize purse for the ideation stage is $100,000.

“We’re looking for creative insights and application of new technology to unleash the full potential of retinal organoids. Our goal is for researchers to be able to generate or obtain retinal organoids easily so that they can be widely used for understanding diseases and testing drugs,” explained Jessica Mazerik, Ph.D., NEI challenge coordinator. “To do this, we are encouraging entries from diverse teams of participants.” They may come from vision research, developmental and stem cell biology, tissue engineering, materials science, 3-D bioprinting, and other fields.

Stage I also has a special solver category exclusively for trainees, which includes graduate and undergraduate students, postdoctoral fellows, and medical students. NEI has launched a discussion forum as a teambuilding space.

So far, nine sponsors have joined the challenge to support solvers through grants, access to expertise and discounted reagents, and in-kind testing.

 

Proposed Stage II: Development

The development stage of the challenge will require demonstration of a functional retina organoid prototype. This stage is planned to launch in fall 2017 and expected to offer $1 million in prize money.

Full details of the 3-D Retina Organoid Challenge prize competition are available at https://nei.nih.gov/3DROC.

 

References:

1. Varma R, Vajaranant TS, Burkemper B, Wu S, Torres M, Hsu C, Choudhury F, McKean-Cowdin R. Visual Impairment and Blindness in Adults in the United StatesDemographic and Geographic Variations From 2015 to 2050. JAMA Ophthalmol.134(7):802-809. doi:10.1001/jamaophthalmol.2016.1284 (2016).

2. Rein, D. B. et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 124, 1754-1760. (2006).


 

You can also read a letter from the Director of the National Eye Institute, Paul Sieving, to Nature here:

https://www.nature.com/nature/journal/v546/n7658/full/546352b.html


 

 

###

NEI leads the federal government’s research on the visual system and eye diseases. NEI supports basic and clinical science programs to develop sight-saving treatments and address special needs of people with vision loss. For more information, visit https://www.nei.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/(link is external).

NIH…Turning Discovery Into Health®

Thumbs up (1 votes)
Loading...

Tags: , ,
Categories: Funding

In Development this week (Vol. 144, Issue 12)

Posted by , on 21 June 2017

Here are the highlights from the current issue of Development:

 

Btbd7 branches out across multiple organs

Dynamic changes in epithelial cell-cell adhesion and motility are crucial for branching morphogenesis – the process by which highly branched epithelial organs, such as the lung and kidney, grow and develop from a simple epithelial bud. Although many key regulatory factors involved in branching morphogenesis have been identified, it remains unclear how they coordinate to control epithelial cell dynamics.

In this issue (p. 2200), the Yamada laboratory presents strong evidence for the essential role of Btbd7 in orchestrating epithelial remodelling during branching morphogenesis in the mouse lung, kidney and salivary glands in vivo. Specifically, the authors show that loss of Btbd7 in a knockout mouse model results in increased cadherin localisation to cell-cell junctions and reduced motility in the outer cells of epithelial buds. Conversely, Btbd7 overexpression in vitro leads to decreased cell-cell adhesion and increased cell motility. They further show that Btbd7 induces E-cadherin ubiquitination, internalisation and degradation in MDCK epithelial cells, providing a mechanism for how Btbd7 can control cell adhesion and migratory behaviour. Collectively, these data establish for the first time that the new regulatory molecule Btbd7 is required for successful in vivo branching morphogenesis of salivary gland, lung and kidney.

 

Female fertility: no bed of ROS(es)

Oocyte development involves extensive transcriptional and epigenetic changes in order to eventually produce a mature egg competent for fertilisation. Key to this process is the avoidance of apoptosis, but how anti-apoptotic genes are regulated during oogenesis remains largely undefined. Now, on p. 2165, Qinghua Shi and colleagues show that genetic deletion of histone acetyltransferase KAT8 specifically in mouse oocytes at the primordial follicle stage causes the defective development of follicles from the secondary follicle stage, which subsequently leads to female infertility. The authors observe significantly increased reactive oxygen species (ROS) levels in the mutant oocytes, coincident with the downregulation of several antioxidant genes and show via chromatin immunoprecipitation assays that KAT8 regulates antioxidant gene expression by direct binding to promoter regions. Importantly, the authors are able to rescue the defects of folliculogenesis after Kat8 deletion in oocytes by antioxidant administration in mice. This study demonstrates for the first time that KAT8 represses ROS levels in oocytes by promoting the expression of antioxidant genes at the transcriptional level, and provides insight into the epigenetic regulation of female fertility.

 

Sox2+ pituitary stem cells on the MAP(K)

The MAPK/ERK pathway plays an important role in development and disease, with control over multiple cellular processes such as proliferation, differentiation and apoptosis, to name but a few. Despite its importance, little is known regarding its role in pituitary development and, specifically, in regulating the Sox2+ stem cell population therein. Now, on p. 2141, Scott Haston, from the Martinez-Barbera laboratory, and colleagues take a genetic approach to address the function of the MEK/ERK pathway during normal pituitary development, and relate this to human papillary craniopharyngioma (PCP), a form of benign but clinically relevant pituitary tumour. Using a MAPK gain-of-function mouse model, the authors demonstrate that constitutive activation of the MAPK/ERK pathway during pituitary development causes pituitary hyperplasia, abnormal morphogenesis and abnormal endocrine cell specification. This is due to sustained proliferation of the Sox2+ stem cell compartment, which results in an imbalance between proliferation and differentiation and, ultimately, an expansion of Sox2+ cells at the end of gestation. Looking at human PCP samples, the authors provide evidence that sustained proliferation of SOX2+ cells with reduced differentiation potential may contribute to the underlying pathogenesis of PCP. This study is an important step forward in understanding the role of the MAPK/ERK pathway in pituitary development, and sheds light on the possible pathogenesis of human PCP.

 

A new model for single-cell delamination

Epithelial cell delamination – the process by which individual epithelial cells detach from an epithelial layer – is a common phenomenon throughout development and can be observed across a wide range of species. Despite its prevalence, it remains unclear whether the mechanism that drives single-cell delamination varies according to the context and, if so, how.

In this issue (p. 2153), Yan Yan and colleagues investigate the mechanism of neuroblast delamination in the Drosophila embryo and find that it differs to that previously reported for epithelial homeostasis. Using an elegant combination of live imaging, genetics, pharmacology and mathematical modelling, the authors describe a new mechanism for cell delamination in which the neuroblasts undergo incremental apical constriction, which coincides with pulses of myosin accumulation at their medial apical cortex. By contrast, the accumulation of junctional myosin only has a weak correlation with apical constriction.

The authors demonstrate that the quantitative difference in the frequency and magnitude of myosin pulses critically determines whether a cell will effectively constrict, and further provide evidence for the possibility that this is regulated by the same signal that defines the neuroblast cell fate, namely, Notch. This study establishes a mechanism for cell delamination that is distinct from the previously reported mechanism, and opens up a new area of research into the possibility of Notch signalling upstream of dynamic cytoskeletal rearrangements.

 

MSPd signalling: new roles in muscle and reproduction

Amyotrophic lateral sclerosis (ALS), which is also known as Lou Gehrig’s disease and motor neurone disease (MND), is a debilitating disease that causes the death of both cortical and spinal motor neurons, resulting in a loss of control over voluntary muscle. There is currently no cure for ALS, and the origin of the disease is largely unknown. In previous studies, VAMP/synaptobrevin-associated proteins (VAPs) have been associated with ALS and spinal muscular atrophy (SMA): specifically, the N-terminal major sperm protein domain (MSPd), which serves as an extracellular signalling molecule and which is mutated in some forms of familial ALS. In this issue, Sung Min Han, Michael Miller and colleagues investigate the molecular framework and functional consequences of MSPd signalling in C. elegans, with implications for muscle and gonad development.

In the first study (p. 2175), the authors focus on the role of MSPd in muscle formation, based on the expression of VPR-1, the C. elegans homologue of human VAPB. The authors show that secreted MSPds promote the localisation of mitochondria within the body wall muscle during development, and that this is dependent on signalling events that involve the CLR-1 Lar-like phosphatase receptor. Using a targeted RNAi screen of known genes implicated in ALS and SMA, the authors identified survival of motor neuron 1 (SMN-1) as a crucial downstream mediator of MSPd and further showed that SMN-1 and ARX-2 are important for mitochondria localisation along the I-bands in body wall muscle.

In the second study (p. 2187), the authors turn their attention to the role of VPR-1 in gonad development, an area in which the role of VPR-1 remains largely unexplored. Taking a genetic approach, the authors show that vpr-1 null mutants are sterile upon hatching, a defect in gonadogenesis that can be rescued by the expression of MSPd from almost any tissue, except for the somatic gonad itself. The authors further demonstrate that, under normal conditions, gonad development depends on germline and neuronal expression of vpr-1 and specifically on cleaved MSPd, which circulates in the pseudocoelom and induces gonadogenesis non-cell-autonomously, much like a hormone.

Together, these two studies represent a major step forward in our understanding of the function of the vpr-1 gene in C. elegans, and also demonstrate the utility of this organism in elucidating disease mechanisms.

 

 

Plus…

Human development, heredity and evolution

This Meeting Review of the 2017 RIKEN-CDB Symposium summarises recent progress in our understanding of human development, genetics and our evolutionary history.

 

Making muscle: skeletal myogenesis in vivo and in vitro

This Review discusses the mechanisms that underpin the formation of skeletal muscle during development and its recapitulation from pluripotent stem cells in vitro.

 

Development of the thyroid gland

This Review discusses the principal mechanisms involved in thyroid organogenesis, highlighting the factors involved in thyroid progenitor specification and the events occurring during thyroid gland morphogenesis.

 

Thumbs up (No Ratings Yet)
Loading...

Categories: Research

Post-doc in evolutionary and developmental genetics at UPenn

Posted by , on 20 June 2017

Closing Date: 15 March 2021

Kamberov Laboratory, Department of Genetics in the Perelman School of Medicine at the
University of Pennsylvania, USA.

Post-doctoral positions are available in the field of evolutionary and developmental
genetics.

Our lab’s research focuses on unraveling the developmental networks and genetic changes that underlie the divergence of humans from other species and for the diversity of present-day human populations. We are broadly interested in evolution of humans, but the core focus of the lab is on the skin and its appendages. We pursue these goals in order to not only understand the genetic origins of human specialization and variation but also seek to apply our findings to the betterment of human health.  Available projects include: dissection of genetic pathways of skin appendage development and regeneration in mouse models; discovery and modeling of human adaptive variants using transgenic mice; high throughput screening for genetic elements controlling the development and uniqueness of human skin appendages.

A doctorate in biology or related field is required. Applicants with a strong background in genetics/genomics, developmental biology and molecular biology are encouraged to apply.

Interested candidates should provide: 1) your CV 2) A brief letter detailing your interest in the lab and relevant past research experience 3) The contact information for three references who can comment on your research. Application materials and any questions regarding the position should be sent to Yana Kamberov: yana2@mail.med.upenn.edu

Thumbs up (No Ratings Yet)
Loading...

Categories: Jobs

One more day to vote!

Posted by , on 20 June 2017

Our image competition for a future Development cover is still live: voting closes tomorrow at 13.00 GMT! Click here to vote and find out more about the images

 

Thumbs up (No Ratings Yet)
Loading...

Categories: Images

Postdoctoral Position in Signaling Mechanisms during Organogenesis at the Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California

Posted by , on 20 June 2017

Closing Date: 15 March 2021

An NIH-funded postdoctoral position is available to investigate the signaling functions of retinoic acid (RA) during mouse embryo development. Our laboratory has reviewed recent advances in this field: Cunningham, T.J. and Duester, G. Mechanisms of retinoic acid signalling and its roles in organ and limb development. Nature Reviews Molecular Cell Biology 16: 110-123 (2015).

 

We are searching for a Postdoctoral Associate to explore the mechanisms of RA signaling and nuclear receptor coregulators during the early stages of organogenesis and limb formation using CRISPR/Cas9 gene editing, RNA-seq transcriptome analysis, and embryo chromatin immunoprecipitation.

 

Candidates should have a strong background in developmental biology or stem cell biology. Salary $47,476 with full benefits.

 

Interested applicants should email their CV and names of three references to:

Gregg Duester, Ph.D.

Professor

Development, Aging, and Regeneration Program

Sanford Burnham Prebys Medical Discovery Institute

10901 North Torrey Pines Road

La Jolla, California 92037, USA (San Diego area)

duester@sbpdiscovery.org

 

For more information please visit the Lab Website:

http://www.sbpdiscovery.org/Talent/Pages/GreggDuester.aspx

Thumbs up (No Ratings Yet)
Loading...

Categories: Jobs